Active Targeted Janus Theranostic Nanoplatforms Enable Chemo-Photothermal Therapy to Inhibit the Growth of Breast Cancer
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.3c00669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Xiangjun Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shandong New Drug Loading & Release Technology and Preparation Engineering Laboratory, Binzhou Medical University, 346 Guanhai Ro…. Hauptthemen laut MEDLINE: Breast Neoplasms, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Taishan Scholar Project of Shandong Province, Binzhou Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Nanoscale structures have been developed to serve various functions in cancer therapy, encompassing areas such as diagnosis, biomedical visualization, tissue regeneration, and drug delivery. Based on biocompatible chitosan oligosaccharides (COS) and gold nanorods (GNRs), we designed the drug delivery systems (GNR@polyacrylic acid-Mn@COS Janus nanoparticles (JNPs)), which achieved paclitaxel (PTX) loaded on the side of GNRs, and the PAA-Mn domain served as magnetic resonance imaging contrast agents. This system was found to be effectively delivered to tumor sites through the enhanced permeability and retention (EPR) effect and the active target of the COS. The uniform JNPs selectively targeted cancer cells instead of normal cells through interacting with the COS on the surface of tumor cells, and the pH/NIR-responsive drug release behavior further enhanced their therapeutic effects. The in vivo effects of JNPs against tumors were evaluated using subcutaneous and orthotopic lung metastasis models, yielding promising outcomes for both tumor diagnosis and cancer treatment. In conclusion, the obtained JNPs hold great promise as a theranostic nanoplatform with synergistic chemotherapeutic and photothermal effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shandong New Drug Loading & Release Technology and Preparation Engineering Laboratory, Binzhou Medical University, 346 Guanhai Road, Yantai 264003, P. R. China.
ORCID-Profile: Xiangjun Chen, Wenting Li, Wei Hong
Förderung
- Taishan Scholar Project of Shandong Province
- Binzhou Medical University
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Chen, X., Hou, M., Zhang, X., Liu, H., Li, W., & Hong, W. (2023). Active Targeted Janus Theranostic Nanoplatforms Enable Chemo-Photothermal Therapy to Inhibit the Growth of Breast Cancer. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00669
Vancouver
Chen X, Hou M, Zhang X, Liu H, Li W, Hong W. Active Targeted Janus Theranostic Nanoplatforms Enable Chemo-Photothermal Therapy to Inhibit the Growth of Breast Cancer. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.3c00669
BibTeX
@article{Chen2023,
author = {Chen, Xiangjun and Hou, Mingyi and Zhang, Xinzhong and Liu, Haixin and Li, Wenting and Hong, Wei},
title = {Active Targeted Janus Theranostic Nanoplatforms Enable Chemo-Photothermal Therapy to Inhibit the Growth of Breast Cancer},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.3c00669}
}
EUVIMED